ODAN-PHENYLEPHRINE 2.5 %
PHENYLEPHRINE HYDROCHLORIDE : 2.5 % · DIN 00622915 · ODAN LABORATORIES LTD
Health Canada status: DORMANT
What is ODAN-PHENYLEPHRINE?
ODAN-PHENYLEPHRINE 2.5 % contains PHENYLEPHRINE HYDROCHLORIDE : 2.5 %. It is listed in the Health Canada Drug Product Database under DIN 00622915, held by ODAN LABORATORIES LTD, supplied as SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as dormant, status dated 22-Jun-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ODAN-PHENYLEPHRINE used for?
Ophthalmic decongestant and vasoconstrictor for pupil dilation in uveitis, wide angle glaucoma, surgery, refraction, ophthalmoscopic examination and diagnostic procedures.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00622915 |
|---|---|
| Brand name | ODAN-PHENYLEPHRINE |
| Generic / active ingredient | PHENYLEPHRINE HYDROCHLORIDE : 2.5 % |
| Manufacturer | ODAN LABORATORIES LTD |
| Strength | 2.5 % |
| Dosage form | SOLUTION |
| Route of administration | OPHTHALMIC |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | S01FB01 PHENYLEPHRINE |
| AHFS class | 52:24.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 22-Jun-2017 |
| Original market date | 1985-12-31 00:00:00 |
How is it administered?
Topically, 1 or 2 drops into the conjunctiva of each eye for refraction or ophthalmoscopic examination. May be applied 30 to 60 minutes prior to surgery.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store between 2°C and 30°C, protect from light. Keep container tightly closed.
How is it supplied?
15 mL plastic squeeze bottles with dropper tip.
Contraindications
Narrow-angle glaucoma, hypertension, and in persons with a known hypersensitivity to any component.
Warnings and precautions
For topical ophthalmic use only. Use with caution in patients with advanced arteriosclerotic conditions or severe hypertension. Do not use if solution is discolored.
Is PHENYLEPHRINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code S01FB01 PHENYLEPHRINE. 3 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MINIMS PHENYLEPHRINE HYDROCHLORIDE | 10 % | SOLUTION | BAUSCH & LOMB INC | MARKETED | DIN 02148455 |
| MINIMS PHENYLEPHRINE HYDROCHLORIDE | 2.5 % | SOLUTION | BAUSCH & LOMB INC | MARKETED | DIN 02148447 |
| MYDFRIN | 2.5 % | SOLUTION | ALCON CANADA INC | MARKETED | DIN 00465763 |
| PHENYLEPHRINE | 2.5 % | SOLUTION | PHARMA STULLN INC. | DORMANT | DIN 02027100 |
Who else supplies PHENYLEPHRINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PHENYLEPHRINE appears in 51 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.